Bruce Rankin
Family Medicine · Deland, FLNPI 1922027853
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (58.9%), food and beverage and gifts — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Pfizer at 25.7% of the total. Reporting peaked in 2019 at $6,374 and has fallen 96.1% since, to $250 in 2025. Among family medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 193 payments — averaging $64.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$3K
- Modernatx, Inc.$3K
- Merck$2K
- Chiesi USA, Inc.$1K
- AstraZeneca$466
- Novo Nordisk$344
- plus $2K from 18 others
Across 5,784 payments — averaging $6343.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$16.1M
- Pfizer$7.7M
- Janssen Research & Development, LLC$3M
- Sanofi Pasteur Inc.$2.8M
- Emergent Biosolutions Inc.$1.5M
- Eli Lilly$1.3M
- plus $4.2M from 34 others
What the payments were for
- Travel & lodging$7,34559%
- Food & beverage$5,09941%
- Education$60%
- Gifts$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 23 | $3,205 |
| Modernatx, Inc. | 15 | $2,922 |
| Merck | 20 | $2,326 |
| Chiesi USA, Inc. | 3 | $1,400 |
| AstraZeneca | 26 | $466 |
| Novo Nordisk | 18 | $344 |
| Teva Pharmaceuticals USA, Inc. | 11 | $266 |
| AbbVie(2 entities) | 15 | $256 |
| Lilly USA, LLC | 12 | $252 |
| Astellas Pharma US Inc | 10 | $185 |
| Amgen | 4 | $166 |
| Boehringer Ingelheim | 9 | $148 |
| Gilead | 1 | $125 |
| GSK | 8 | $108 |
| Amarin Pharma, Inc. | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $53 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| Novartis | 2 | $36 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Cardiovascular Systems Inc. | 1 | $21 |
| Bayer | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| Antares Pharma, Inc. | 1 | $14 |
| IBSA Pharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- V114$1,912
- PREVNAR - 13$1,089
- Austedo XR$125
- Descovy$125
- Repatha$121
How this compares
$12,470 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Deland
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
- Samuel GreenleePensacola$235K
- Kevin FitzgeraldStuart$198K
- Louis KuritzkyGainesville$186K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.